{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:02:07Z","timestamp":1791273727743,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007579","name":"Auburn University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007579","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.lfs.2016.02.072","type":"journal-article","created":{"date-parts":[[2016,2,28]],"date-time":"2016-02-28T18:45:40Z","timestamp":1456685140000},"page":"24-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Methamphetamine-induced dopaminergic toxicity prevented owing to the neuroprotective effects of salicylic acid"],"prefix":"10.1016","volume":"154","author":[{"given":"Bessy","family":"Thrash-Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senthilkumar S.","family":"Karuppagounder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwipayan","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuj","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishnu","family":"Suppiramaniam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muralikrishnan","family":"Dhanasekaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2016.02.072_bb0005","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0006-2952(02)01174-7","article-title":"Glutathione, iron and Parkinson's disease","volume":"64","author":"Bharath","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2016.02.072_bb0010","first-page":"1457","article-title":"Aetiology of Parkinson's disease","volume":"2","author":"Caine","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2016.02.072_bb0015","series-title":"Oxygen Radicals and Tissue Injury","first-page":"130","article-title":"Oxygen radicals and Parkinson's disease","author":"Cohen","year":"1988"},{"key":"10.1016\/j.lfs.2016.02.072_bb0020","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/ptr.2109","article-title":"Antiparkinson drug\u2014Mucuna pruriens shows antioxidant and metal chelating activity","volume":"22","author":"Dhanasekaran","year":"2008","journal-title":"Phytother. Res."},{"issue":"3","key":"10.1016\/j.lfs.2016.02.072_bb0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0163-7258(98)00042-4","article-title":"The role of excitotoxicity in neurodegenerative disease: implications for therapy","volume":"81","author":"Doble","year":"1999","journal-title":"Pharmacol. Ther."},{"issue":"2\u20133","key":"10.1016\/j.lfs.2016.02.072_bb0030","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0022-510X(87)90121-3","article-title":"Motor function in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse","volume":"77","author":"Donnan","year":"1987","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.lfs.2016.02.072_bb0035","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/0028-3908(88)90071-8","article-title":"Regional distribution of ubiquinones and tocopherols in the mouse brain: lowest content of ubiquinols in the substantia nigra","volume":"27","author":"Fariello","year":"1988","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.lfs.2016.02.072_bb0040","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1742-2094-7-45","article-title":"Effects of mitochondrial dysfunction on the immunological properties of microglia","volume":"7","author":"Ferger","year":"2010","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.lfs.2016.02.072_bb0045","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s002109900079","article-title":"Salicylate protects against MPTP-induced impairments in dopaminergic neurotransmission at the striatal and nigral level in mice","volume":"360","author":"Ferger","year":"1999","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.lfs.2016.02.072_bb0050","first-page":"737","article-title":"Free radicals, reactive oxygen species and human disease: a critical evaluation with special reference to atherosclerosis","volume":"70","author":"Halliwell","year":"1989","journal-title":"Br. J. Exp. Pathol."},{"key":"10.1016\/j.lfs.2016.02.072_bb0055","series-title":"Goodman and Gilman's the Pharmacological Basis of Therapeutics","first-page":"1905","author":"Hardman","year":"1996"},{"key":"10.1016\/j.lfs.2016.02.072_bb0060","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3109\/10715769709065781","article-title":"Hydroxyl radicals scavenging activity of nonsteroidal anti-inflammatory drugs","volume":"27","author":"Kataoka","year":"1997","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.lfs.2016.02.072_bb0065","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1289\/ehp.7571","article-title":"Early environmental origins of neurodegenerative disease in later life","volume":"113","author":"Landrigan","year":"2005","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.lfs.2016.02.072_bb0070","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1289\/ehp.6361","article-title":"Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation","volume":"111","author":"Liu","year":"2003","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.lfs.2016.02.072_bb0075","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1432-1033.1974.tb03714.x","article-title":"Involvement of superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase","volume":"47","author":"Marklund","year":"1974","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.lfs.2016.02.072_bb0080","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.lfs.2016.02.072_bb0085","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0006-8993(00)02189-2","article-title":"Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity","volume":"864","author":"Mohanakumar","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.lfs.2016.02.072_bb0090","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0160-5402(85)90021-X","article-title":"An improved fluorimetric assay for brain monoamine oxidase","volume":"13","author":"Morinan","year":"1985","journal-title":"J. Pharmacol. Methods"},{"key":"10.1016\/j.lfs.2016.02.072_bb0095","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0006-8993(00)02994-2","article-title":"SKF-38393, a dopamine receptor agonist, attenuates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- induced neurotoxicity","volume":"892","author":"Muralikrishnan","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.lfs.2016.02.072_bb0100","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1096\/fasebj.12.10.905","article-title":"Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice","volume":"12","author":"Muralikrishnan","year":"1998","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.lfs.2016.02.072_bb0105","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/syn.10239","article-title":"d-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity","volume":"50","author":"Muralikrishnan","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.lfs.2016.02.072_bb0110","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1196\/annals.1432.032","article-title":"Defining \u201cneuroinflammation\u201d","volume":"1139","author":"O'Callaghan","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.lfs.2016.02.072_bb0115","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0166-2236(93)90070-3","article-title":"A radical hypothesis for neurodegeneration","volume":"16","author":"Olanow","year":"1993","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.lfs.2016.02.072_bb0120","series-title":"Inhibition of Mitochondrial NADH Dehydrogenase by Pyridine Derivatives and Its Possible Relation to 269\u2013275","author":"Ramsay","year":"1986"},{"issue":"22","key":"10.1016\/j.lfs.2016.02.072_bb0125","doi-asserted-by":"crossref","first-page":"5756","DOI":"10.1523\/JNEUROSCI.1179-08.2008","article-title":"Methamphetamine causes microglial activation in the brains of human abusers","volume":"28","author":"Sekine","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2016.02.072_bb0130","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/(SICI)1097-4547(19990315)55:6<659::AID-JNR1>3.0.CO;2-C","article-title":"Cytotoxic and genotoxic potential of dopamine","volume":"55","author":"Stokes","year":"1999","journal-title":"J. Neurosci. Res."},{"issue":"24","key":"10.1016\/j.lfs.2016.02.072_bb0135","doi-asserted-by":"crossref","first-page":"9207","DOI":"10.1523\/JNEUROSCI.20-24-09207.2000","article-title":"The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease","volume":"20","author":"Thiruchelvam","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2016.02.072_bb0140","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11064-009-0042-5","article-title":"Neurotoxic effects of methamphetamine","volume":"35","author":"Thrash","year":"2010","journal-title":"Neurochem. Res."},{"issue":"6","key":"10.1016\/j.lfs.2016.02.072_bb0145","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S1734-1140(09)70158-6","article-title":"Methamphetamine-induced neurotoxicity: the road to Parkinson's disease","volume":"61","author":"Thrash","year":"2009","journal-title":"Pharmacol. Rep."},{"issue":"10","key":"10.1016\/j.lfs.2016.02.072_bb0150","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1007\/s11064-013-1117-x","article-title":"Assessment of therapeutic potential of amantadine in methamphetamine induced neurotoxicity","volume":"38","author":"Thrash-Williams","year":"2013","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.lfs.2016.02.072_bb0155","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.lfs.2007.07.018","article-title":"Evaluation of neuroprotective and anti-fatigue effects of sildenafil","volume":"81","author":"Uthayathas","year":"2007","journal-title":"Life Sci."},{"issue":"21","key":"10.1016\/j.lfs.2016.02.072_bb0160","doi-asserted-by":"crossref","first-page":"13371","DOI":"10.1073\/pnas.222543099","article-title":"Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?","volume":"99","author":"Warner","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.lfs.2016.02.072_bb0165","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0304-3940(88)90443-0","article-title":"Acute stress or neuroleptics elicit sensorimotor deficits in MPTP-treated mice","volume":"85","author":"Weihmuller","year":"1988","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.lfs.2016.02.072_bb0170","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0076-6879(67)10048-7","article-title":"Cytochrome oxidase from beef heart mitochondria","volume":"10","author":"Wharton","year":"1967","journal-title":"Methods Enzymol."},{"issue":"3","key":"10.1016\/j.lfs.2016.02.072_bb0175","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0091-3057(97)90010-1","article-title":"Effects of salicylate on 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity in rats","volume":"58","author":"Yeh","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.lfs.2016.02.072_bb0180","first-page":"607","article-title":"Methamphetamine induced cell death: selective vulnerability in neuronal subpopulations of the striatum in mice","volume":"140","author":"Zhu","year":"2006","journal-title":"Neuropharmacology"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320516301229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320516301229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T07:13:14Z","timestamp":1617606794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320516301229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":36,"alternative-id":["S0024320516301229"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2016.02.072","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methamphetamine-induced dopaminergic toxicity prevented owing to the neuroprotective effects of salicylic acid","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2016.02.072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}